Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M27.1Revenue (TTM) $M2.1Net Margin (%)-876.2Altman Z-Score-88.9
Enterprise Value $M33.6EPS (TTM) $-2.6Operating Margin %-858.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-876.1Higher ROA y-yY
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio0.3Cash flow > EarningsY
Price/Sales6.05-y EBITDA Growth Rate %--Current Ratio0.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-228.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-1,825.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M17.5ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BIOC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BIOC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIOC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Neff Edward A.Director 2016-10-19Buy227,272$1.139.09view
HALE DAVID FDirector 2016-10-19Buy90,909$1.139.09view
Nall Michael W.CEO & President 2016-10-19Buy36,363$1.139.09view
Chandler Marsha AlpertDirector 2016-10-19Buy4,545$1.139.09view
Kennedy TimothyCFO, Sr V.P. Operations & Sec. 2016-10-19Buy36,363$1.139.09view
HUEBNER BRUCE ADirector 2016-10-19Buy20,000$1.139.09view
Gerhardt BruceDirector 2016-10-19Buy50,000$1.139.09view
Singh VeenaSr VP & Sr Med Director 2016-10-19Buy10,000$1.139.09view
ARNOLD LYLE JSR VP of R&D and CSO 2016-10-19Buy45,000$1.139.09view
Wilson Margaret FayeDirector 2016-10-19Buy13,636$1.139.09view

Quarterly/Annual Reports about BIOC:

    News about BIOC:

    Articles On GuruFocus.com
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 

    More From Other Websites
    ETFs with exposure to Biocept, Inc. : January 19, 2017 Jan 19 2017
    Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture... Jan 19 2017
    Latest Reports on Biocept and Apricus Biosciences as President Trump's Comments Put Pressure on Drug... Jan 13 2017
    Tuesday’s Top Biopharma Movers Jan 10 2017
    Biocept Secures In-Network Provider Agreement with Blue Cross Blue Shield of Texas Jan 10 2017
    Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to... Dec 27 2016
    Columbia University Medical Center Sponsors Clinical Study Using Biocept's Liquid Biopsy Platform to... Dec 27 2016
    Clinical Utility of Biocept's Liquid Biopsy Platform Demonstrated in Study Results Presented at the... Dec 08 2016
    Biocept Presents Robust Analytical Validation Study Results for its PD-L1 Liquid Biopsy Test at the... Dec 07 2016
    Teladoc November Visits Set Record: Why is Stock Suffering? Dec 07 2016
    ETFs with exposure to Biocept, Inc. : December 5, 2016 Dec 05 2016
    BIOCEPT INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule... Dec 02 2016
    Biocept to Present at the LD Micro Main Event Nov 21 2016
    BIOCEPT INC Financials Nov 18 2016
    ETFs with exposure to Biocept, Inc. : November 14, 2016 Nov 14 2016
    BIOCEPT INC Files SEC form 10-Q, Quarterly Report Nov 10 2016
    Biocept, Inc. :BIOC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 10, 2016 Nov 10 2016
    Biocept Reports 2016 Third Quarter Financial Results Nov 09 2016
    BIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 09 2016
    Biocept Reports 2016 Third Quarter Financial Results Nov 09 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)